[Form 4] Expensify, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Expensify, Inc. (EXFY) Form 4: The reporting person, Muralidharan Anuradha, who is listed as Chief Operating Officer and a director, reported the sale of 25,245 shares of Class A common stock on 08/27/2025 at a weighted average price of $1.94 to $1.96. After the reported transaction the reporting person beneficially owned 61,041 shares (direct ownership). The filing was executed by attorney-in-fact Ryan Schaffer and includes a footnote that the reported price is a weighted average from multiple sales.

Positive

• Transparent disclosure of insider sale with transaction date, share amount, and weighted average price range
• Post-transaction holdings reported (61,041 shares), providing clarity on continuing ownership
• Footnote commitment to provide detailed breakdowns of number of shares sold at each price within the reported range

Negative

• Sale reduces direct holdings by 25,245 shares as reported (no prior total holdings shown on this form to provide full context)
• No information on motivation or trading plan is provided on this Form 4 to explain the sale (not required but limits context)

Insights

Securities Analyst

TL;DR: Routine insider sale disclosed; materiality appears limited absent additional context on total holdings or timing.

The Form 4 shows a straightforward disposition of 25,245 Class A shares by the COO/director at a weighted average price between $1.94 and $1.96 on 08/27/2025. The filing includes the post-transaction beneficial holding of 61,041 shares, indicating continued direct ownership. No derivative transactions or exercise events are reported. This is a standard Section 16 disclosure that ensures market transparency but by itself does not convey broader corporate or financial changes.

Corporate Governance Expert

TL;DR: Disclosure complies with Section 16 reporting; sale appears properly documented with weighted average price footnote.

The report names the reporting person, role (COO and director), the transaction date and the exact share quantity sold, and includes an explanatory footnote about multiple sale prices and willingness to provide detailed breakdowns. The Form 4 was signed by an attorney-in-fact, consistent with permitted authorization. There are no indications of related-party transactions, options exercises, or plan-based trades disclosed on this form.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Muralidharan Anuradha

(Last) (First) (Middle)

C/O EXPENSIFY, INC. 401 SW 5TH AVE

(Street)

PORTLAND OR 97204

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Expensify, Inc. [ EXFY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Operating Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/27/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	08/27/2025		S		25,245	D	$1.94(1)	61,041	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.94 to $1.96, inclusive. The reporting person undertakes to provide to Expensify, Inc., any security holder of Expensify, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Remarks:

	/s/ Ryan Schaffer, as attorney-in-fact	09/05/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider filed the Form 4 for Expensify (EXFY)?

The reporting person is Muralidharan Anuradha, listed as Chief Operating Officer and a director.

How many shares were sold by the insider and when?

The insider sold 25,245 shares of Class A common stock on 08/27/2025.

At what price were the shares sold according to the Form 4?

The shares were sold at a weighted average price between $1.94 and $1.96, per the filing footnote.

How many shares does the insider beneficially own after the sale?

After the reported transaction the insider beneficially owned 61,041 shares (direct ownership).

Were any derivative transactions or option exercises reported?

No. Table II (derivative securities) shows no reported transactions in this filing.

Who signed or executed the Form 4 filing?

The Form 4 was executed by Ryan Schaffer as attorney-in-fact on 09/05/2025.